SELLAS Life Sciences Group, Inc.Letter Agreement • April 30th, 2019 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This letter agreement (the "Letter Agreement") confirms our agreement concerning your resignation and separation from SELLAS Life Sciences Group, Inc. (the "Company") and the transition of your responsibilities as Executive Vice President and Chief Medical Officer (collectively, "CMO"). By entering into this Letter Agreement, the Company and you agree to the terms and conditions set forth herein.
